Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Amerikaanse aandelen Terug naar discussie overzicht

Legale wiet

1.143 Posts
Pagina: «« 1 ... 17 18 19 20 21 ... 58 »» | Laatste | Omlaag ↓
  1. winst is winst 11 februari 2014 09:59
    quote:

    nhp22 schreef op 11 februari 2014 09:47:

    [...]

    IDD is er nieuws? of zijn beleggers geschrokken van het nieuws van de ontruimingen in Noord-Braband ;)?
    :>)
    heb gisteren nog een paar haaltjes genomen,best lekker in combinatie met een wit zoet wijntje.
  2. winst is winst 11 februari 2014 10:27
    quote:

    welshterrier schreef op 11 februari 2014 10:20:

    volgens mij heb je teveel gerookt....lol
    :>)
    tegenwoordig lukt dat niet meer,val ik om,en met een beetje pech op het toetsenbord met als gevolg verkeerde orders.
    dus rustig aan maar :>)
  3. nhp22 11 februari 2014 11:43
    Nee, sorry vrienden en vriendinnen, ik rook niet. Anyway Peace ;). Ben benieuwd wat vandaag gaat brengen In engeland Staat GW Pharmaceuticals 1% hoger. Wellicht een indicatie
  4. [verwijderd] 11 februari 2014 13:42
    Dewm

    Dewmar International BMC, Inc. (OTCQB: DEWM) Signs Co-Branding & Consultant Services Agreement With Hemp, Inc. (OTC Pink: HEMP)

    Date : 02/11/2014 @ 4:45AM
    Source : Marketwired
    Stock : Dewmar International Bmc, Inc. (QB) (DEWM)
    Quote : 0.0041 -0.0007 (-14.58%) @ 5:00PM



    Dewmar International BMC, Inc. (OTCQB: DEWM) Signs Co-Branding & Consultant Services Agreement With Hemp, Inc. (OTC Pink: HEMP)




    Print



    Dewmar Intl Bmc (USOTC:DEWM)
    Intraday Stock Chart

    Today : Tuesday 11 February 2014
    Click Here for more Dewmar Intl Bmc Charts. Dewmar International BMC, Inc. (OTCQB: DEWM) Signs Co-Branding and Consultant Services Agreement With Hemp, Inc. (OTC Pink: HEMP)

    LAS VEGAS, NV--(Marketwired - Feb 11, 2014) - Dewmar International BMC, Inc. (OTCQB: DEWM) (OTCBB: DEWM) ("Dewmar" or "Company") announced today that in the interest of the Company's major expansion plans into the industrial hemp and medical marijuana industries, the Company has secured a co-branding and professional consulting services agreement with The Industrial Hemp and Medical Marijuana Consulting Company, Inc., a wholly-owned subsidiary of Hemp, Inc. (OTC Pink: HEMP).

    "Following an extensive face-to-face meeting in Las Vegas last month with Hemp, Inc. CEO, Bruce Perlowin and his advisors, both teams immediately recognized a natural synergy, and the potential to leverage each other's strengths to take full advantage of this 'once-a-quarter-century' boom that we are soon to experience within the industrial hemp and related industries," said Marco Moran, CEO of Dewmar International BMC, Inc.

    Dr. Moran added, "We look forward to continuing to identify beneficial relationships to broaden Dewmar's international consumer footprint with pioneers such as Mr. Perlowin. He was years ahead of everyone in recognizing the many applications of the hemp plant and the enormous economic opportunity. The world is just beginning to catch up with his insight. Bruce Perlowin and Hemp, Inc. are the perfect partners."

    According to the signed agreement between the two companies, both companies have created a co-branding partnership whereas they will work together to strategically launch a series of consumable goods that stem from the functional and nutritional components of hemp, which will qualify to be sold in all 50 states.

    Bruce Perlowin, CEO of Hemp, Inc. said, "On January 22nd of this year, I had the opportunity to sit down with Dr. Moran at an industry conference. I was quite impressed with his Company and the plans that he has to introduce products infused with hemp into the marketplace over the very short term. We believe that the ultimate economic opportunity that is being created by the new legislation regarding hemp farming is incalculable. Hemp oil, seeds and fiber can be used in many different products and it makes the products better, stronger and greener than the current products on the market. Since Dr. Moran is a licensed pharmacist with extensive relationships within the healthcare community, I believe he will also take advantage of opportunities within healthcare."

    Having Hemp, Inc.'s guidance during this great time of growth and expansion for Dewmar International, will allow the company to take advantage of the opportunity existing in the industrial hemp and medical marijuana sector. Dewmar recently reported that it anticipates significant revenue growth for this first quarter of 2014 and has confirmed that it has shed all 'toxic' funders who had placed significant downward pressure on the stock in the previous 12 months. "I believe the public has confidence in the strength and direction of our Company which is creating an influx of business opportunities and potential relationships for Dewmar," said CEO, Dr. Marco Moran. "In addition to positioning the Company for significant and diverse revenue streams for the future, our staff has taken a team approach in reducing our operating costs and total overhead to help improve profitability."

    About Dewmar International BMC, Inc.

    Dewmar International BMC, Inc. is a leading provider of consumer brands to global markets. The Company's flagship product, LEAN SLOW MOTION POTION™ whose three flavors are Yella, Purp and Easta Pink, is rated as one of the top 3 national selling relaxation beverages currently available in the U.S. market, Trinidad & Tobago, Puerto Rico and Mexico. The Company has entered into significant relationships and business discussions intended to leverage the explosion in national popularity of both the industrial hemp and medical marijuana industry, and forecasts a strong presence in the space for the immediate and long-term future. The company has offices in Clinton, Mississippi; Houston, Texas and Las Vegas, Nevada.

    For more information about our Company please visit us at www.DewmarInternational.com. If you are a distributor or retailer inquiring about purchasing our product for resale, please contact us at 1-877-SIP-LEAN or 1-877-747-5326. If you are an Investor please contact us at InvestorRelations@DewmarInternational.com

    ABOUT HEMP, INC.

    Hemp, Inc. (OTC Pink: HEMP) focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. (OTC Pink: HEMP) is not involved in the cultivation or marketing of medical marijuana. It is the company's belief that legalization of hemp in all 50 states and at the federal level will come to pass. With that in mind, the company is building infrastructure with the potential to gain substantial market share before and after industrial hemp prohibition ends. (Pending any federal licensing or other requirements, that may be enacted after hemp prohibition ends).

    ABOUT THE INDUSTRIAL HEMP AND MEDICAL MARIJUANA CONSULTING COMPANY, INC.

    The Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) is a wholly owned subsidiary of Hemp, Inc. (OTC Pink: HEMP) that pulls industry information from a vast network of specialists that consists of other public industry, public company CEOs, bankers, investors, lawyers, industry analysts, and non-profits connected to the industry. IHMMCC is entrenched in all the multi-faceted opportunities in the medical marijuana and Industrial Hemp industry. (www.HempInc.com)

    Safe Harbor Statement
    This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, general economic conditions and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.

    1-877-SIP-LEAN or 1-877-747-5326
    InvestorRelations@DewmarInternational.com


    Mooi pareltje zit er vol in

    Veel succes allemaal
  5. [verwijderd] 11 februari 2014 15:05
    quote:

    WEBJE schreef op 11 februari 2014 15:03:

    weet iemand de openings koers van erbb
    Dat zegt niks op de otc.
    Stand om half 4 is belangrijk.
    Op de otc is geen voor of na beurs handel.
  6. WEBJE 11 februari 2014 15:09
    Ja inderdaad je had dit al gemeld bent een beetje voorzichtig om te kopen nu maar de verleiding is toch groot voor dit aandeel en wat te denken van help ook flink gezakt he ,moet mijn verlies goed maken van tom tom
  7. Tenno 11 februari 2014 16:51
    quote:

    Tenno schreef op 11 februari 2014 16:42:

    op 0.013 en n beetje ingestapt gaande weg omhoog bijkopen
    o,13
1.143 Posts
Pagina: «« 1 ... 17 18 19 20 21 ... 58 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.114
AB InBev 2 5.538
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.138
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.857
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.834
Aedifica 3 926
Aegon 3.258 323.071
AFC Ajax 538 7.088
Affimed NV 2 6.305
ageas 5.844 109.904
Agfa-Gevaert 14 2.062
Ahold 3.538 74.351
Air France - KLM 1.025 35.289
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.050
Alfen 16 25.260
Allfunds Group 4 1.517
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 420
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.854
AMG 971 134.333
AMS 3 73
Amsterdam Commodities 305 6.745
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 496
Antonov 22.632 153.605
Aperam 92 15.055
Apollo Alternative Assets 1 17
Apple 5 386
Arcadis 252 8.806
Arcelor Mittal 2.034 320.965
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.351
Aroundtown SA 1 221
Arrowhead Research 5 9.751
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.606
ASML 1.766 110.042
ASR Nederland 21 4.512
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.919
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.449

Macro & Bedrijfsagenda

  1. 27 maart

    1. Exor Q4-cijfers
    2. Sligro Q4-cijfers
    3. Hennes & Mauritz Q1-cijfers
    4. Fastned Q4-cijfers
    5. Geldhoeveelheid februari (eur)
    6. Steunaanvragen - wekelijks (VS)
    7. Economische groei Q4 def. (VS)
    8. Aanstaande woningverkopen februari (VS)
    9. HAL Q4-cijfers
  2. 28 maart

    1. Producentenprijzen februari (NL)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht